Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada

© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd..

The EnCORE study is a prospective serology study of SARS-CoV-2 in a cohort of children from Montreal, Canada. Based on data from our fourth round of data collection (May-October 2022), we estimated SARS-CoV-2 seroprevalence and seroconversion. Using multivariable regression, we identified factors associated with seroconversion. Our results show that previously seronegative children were approximately 9-12 times more likely to seroconvert during the early Omicron-dominant period compared to pre-Omicron rounds. Unlike the pre-Omicron rounds, the adjusted rate of seroconversion among 2- to 4-year-olds was higher than older age groups. As seen previously, higher seroconversion rates were associated with ethnic/racial minority status.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Influenza and other respiratory viruses - 17(2023), 8 vom: 22. Aug., Seite e13186

Sprache:

Englisch

Beteiligte Personen:

Zinszer, Kate [VerfasserIn]
Charland, Katia [VerfasserIn]
Pierce, Laura [VerfasserIn]
Saucier, Adrien [VerfasserIn]
Hamelin, Marie-Ève [VerfasserIn]
Da Torre, Margot Barbosa [VerfasserIn]
Carbonneau, Julie [VerfasserIn]
Nguyen, Cat Tuong [VerfasserIn]
De Serres, Gaston [VerfasserIn]
Papenburg, Jesse [VerfasserIn]
Boivin, Guy [VerfasserIn]
Quach, Caroline [VerfasserIn]

Links:

Volltext

Themen:

Adolescents
Canada
Children
Journal Article
Research Support, Non-U.S. Gov't
SARS‐CoV‐2
Seroconversion
Seroprevalence

Anmerkungen:

Date Completed 29.08.2023

Date Revised 06.11.2023

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1111/irv.13186

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361362137